Costochondritis (Chronic)
Investigational use for chronic costochondritis after cardiac causes are excluded; no clinical study of leech therapy was identified.
Patient Summary
- Is this FDA-cleared for this use?
- Not FDA-cleared for costochondritis. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is Tier C investigational; no clinical study of leech therapy for costochondritis was identified.
- What evidence exists?
- Tier C (investigational). We did not find any clinical study of leech therapy for costochondritis, so its benefit is unknown. Costochondritis is inflammation at the costochondral or chondrosternal junctions presenting as reproducible chest wall pain. Cardiac causes must be excluded by your physician before any complementary therapy. Conventional management is NSAIDs, topical capsaicin or topical NSAIDs, thoracic mobility exercises, and (refractory cases) local corticosteroid injection.
- Main risks
- Bleeding from bite sites for 6 to 24 hours after detachment
- Bruising and tenderness over the chest wall for 5 to 10 days
- Local skin infection or Aeromonas infection
- Allergic reaction to leech saliva
- Temporary worsening of chest wall pain after the procedure
- Delay of cardiac evaluation if chest pain has not been fully worked up
- Delay of NSAID, topical therapy, and exercise — the evidence-based first-line measures
- Missed alternative diagnosis (shingles, rib fracture, pulmonary pathology)
- Permanent small scars at bite sites on the chest
- Who should not consider this
- Anyone whose chest pain has not been evaluated to exclude cardiac causes
- Patients with active herpes zoster involving the thoracic dermatomes
- Patients with rib fracture or osteomyelitis
- Patients with pneumonia or pleural disease
- Patients on anticoagulants or with anemia
- Patients who have not trialed NSAIDs and thoracic mobility exercises
- Patients with suspected pulmonary embolism, pneumothorax, or aortic dissection
- Patients with active myocardial infarction or unstable angina
- Pregnant patients
- Patients with rib fracture or chest-wall trauma in the past 6 weeks
- What to ask your clinician
- Has cardiac evaluation been completed to confirm musculoskeletal origin?
- Have I trialed NSAIDs, topical agents, and thoracic mobility exercises?
- Has trigger-point injection or local corticosteroid injection been considered for refractory pain?
- Where exactly will the leech be placed, and how far from intercostal nerves?
- What is the realistic expected pain reduction, given that no clinical study of leech therapy for costochondritis was identified?
- What is the practitioner's experience with chest-wall application?
- Have I been evaluated for pulmonary embolism if I have risk factors?
- Are leeches from an FDA-registered supplier and used only once?
- When to seek urgent care
- Sudden severe chest pain, especially with arm/jaw/back radiation or shortness of breath (rule out cardiac event)
- Chest pain with sweating, nausea, or lightheadedness
- Sudden severe shortness of breath (rule out pulmonary embolism)
- Fever above 38.0 C / 100.4 F or chills
- Bleeding from a bite site lasting more than 24 hours
- Spreading redness, warmth, pus, or red streaks at any bite site
- Hives, facial or tongue swelling, throat tightness, or breathing difficulty
What this does NOT mean
- It does not substitute for cardiac evaluation when chest pain has not been worked up.
- It does not work for cardiac, pulmonary, or referred chest pain.
- It does not replace NSAIDs, topical agents, or thoracic mobility exercises.
- No clinical study of leech therapy for this condition was identified; benefit beyond placebo is unestablished.
- It does NOT distinguish musculoskeletal chest pain from serious cardiac or pulmonary disease.
- It does NOT substitute for reassurance and time, which resolve most cases over 6-12 months.
Safety cross-references
Clinical Profile
- Category
- Musculoskeletal
- ICD-10
- M94.0
- Safety tier
- Low
Evidence Summary
Costochondritis is inflammation of the costochondral or chondrosternal junctions presenting as reproducible chest wall pain; cardiac causes must be excluded before any complementary therapy. Conventional management is NSAIDs, topical capsaicin, and trigger point therapy. No clinical study of leech therapy for costochondritis was identified in PubMed, Europe PMC, Crossref or ClinicalTrials.gov, or in the Baskova and Isakhanyan 2004 monograph; use is investigational and mechanistic only, with a presumed local anti-inflammatory rationale. It is distinct from Tietze syndrome (with palpable swelling), for which no leech-therapy study was identified either.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)
Contraindications
- Hemophilia or another bleeding disorder
- Taking anticoagulants (blood thinners such as warfarin or heparin)
- Anemia or suppressed blood formation
- Low blood pressure, shock, collapse or fainting
- Severe wasting (cachexia)
- Intolerance of leeches or a history of severe allergic reactions
- Pregnancy
- Stomach or duodenal ulcer, erosive gastritis
- Acute infectious disease or high fever
- Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
- Drinking alcohol at the time of treatment
- No consent from the patient
- Unevaluated chest pain (cardiac workup required first)
- Active herpes zoster of thoracic dermatome
- Rib fracture or osteomyelitis
- Direct sternal or precordial placement
- Recent thoracic surgery or fracture
- Known costal cartilage neoplasm
Related Conditions
Fibromyalgia
Investigational use only: no controlled clinical study of leech therapy for fibromyalgia was identified, and it is not a primary treatment.
Rotator Cuff Tendinopathy
Investigational use for non-surgical rotator cuff tendinopathy and chronic shoulder impingement; evidence limited to isolated case reports.
Cervical Radiculopathy
Investigational use for cervical radiculopathy; no verifiable published trial specific to this indication.
Knee Osteoarthritis
Off-label use; several small RCTs in knee OA report pain and function improvement with leeches versus NSAID gel, sham leech or TENS, though results against sham and TENS are mixed, and a 2022 trial against physiotherapy found no therapeutic effect.